TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 2 | 5 | 7 | 0 | -5 | 4 | 3 |
| S | %wins | 0 | 0 | 0 | 100 | 100 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/12/21 20:39 | 5/11/21 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Borkowski Edward | FL | O | EVP,Oper | S.d | -46 | 1.04 | 0 | -44 | -43 | 59 | D | ||||||||||||||
2/10/06 17:04 | 2/9/06 | MYL | Mylan Laboratories Inc | PA | Health | Drug | Pharmaceutical Preparations | Borkowski Edward | PA | O | CFO | S.d | -1,756 | 21.95 | 33 | -80 | -64 | 45 | 2 | 5 | 7 | 0 | -5 | 4 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |